35 of 40
Ticker: NVS
Market cap (billions): $120.9
P/E ratio*: 19
Earnings growth**: 14%
Dividend yield: 2.5%

Switzerland-based Novartis, one of the world's leading drugmakers, has divided its business into pharmaceutical, generic and biotech divisions. This three-pronged approach allows the company to weather changes in the economic climate. If one sector falters, the other two should keep Novartis from stumbling.

The company should also be able to keep growing thanks to two cancer treatments with blockbuster potential. In clinical trials, the bone-strengthening drug Zometa and the kidney-cancer drug RAD001 both had unexpected positive effects on breast-cancer patients.

NEXT: FOREIGN VALUE: Philips Electronics
Last updated June 20 2008: 2:35 PM ET
Criteria include low price/earnings and price/book ratios relative to competitors, rising profit margins, and accelerating earnings growth.
*Based on previous 12-months' reported earnings. **Wall Street estimates for the next three years.
Source: Zacks Investment Research
Fortune 40: Full list A complete list of all 40 stocks, with live financial data. (more)
Ultimate mutual fund portfolioIf you crave diversification, stability, and results - but you'd rather leave the hard work to a savvy pro - this collection is for you. (more)
6 real estate bargains The housing downturn's upside? You don't have to go overseas anymore for your dream retirement home. We found the six best markets for deals. (more)

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer. Morningstar: © 2018 Morningstar, Inc. All Rights Reserved. Factset: FactSet Research Systems Inc. 2018. All rights reserved. Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor's Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2018 and/or its affiliates.